Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and quantiplex HIV-1 RNA version 3.0

Journal of Clinical Microbiology

Volumn 39, Issue 3, 2001, Pages 862-870

  Swanson, P ^a   Soriano, V ^a   Devare, S G ^a   Hackett J , Jr ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; VIRUS RNA;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; LABORATORY TEST; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS ISOLATION; VIRUS LOAD;

BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; DNA LIGASES; GENE AMPLIFICATION; HIV INFECTIONS; HIV-1; HUMANS; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES; STAPHYLOCOCCUS PHAGE 3A;

EID: 0035094858     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.3.862-870.2001     Document Type: Article

References (44)

1. Most HIV-1 genetic subtypes have entered Sweden
2. Subtype specific problems with quantification of plasma HIV-1 RNA
3. At least five HIV-1 sequence subypes (A, B, C, D, A/E) occur in England
4. M serotypes in French blood donors over a 10-year period (1985-1995)
5. Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda
6. cnv immunodominant region of HIV type 1 group O from West Central Africa
7. Detection of diverse HIV-1 genetic subtypes in the USA
8. The effects of internal primer-template mismatches on RT-PCR: HIV-1 model studies
9. A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml
10. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma
11. Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as target
12. Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA Quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor Monitor version 1.5
13. Evaluation of the ultrasensitive Roche Amplicor HIV-1 Monitor assay for quantitation of human immunodeficiency virus type 1 RNA
14. gag sequences from Cameroon and Equatorial Guinea
15. First case of HIV-1 subtype O infection in Germany
16. Comparison of the Quantiplex version 3.0 assay and a sensitized Amplicor Monitor assay for measurement of human immunodeficiency virus type 1 RNA levels in plasma samples
17. Human immunodeficiency viruses type 1 subtypes circulating in Spain
18. Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes
19. Detection of human immunodeficiency virus type 1 (HIV-1) DNA and RNA sequences in HIV-1 antibody-positive blood donors in Uganda by the Roche AMPLICOR assay
20. Use of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 to assess the performance of viral RNA quantitation tests
21. The Abbott LCx HIV RNA quantitative assay: A new ultrasensitive assay for quantitation of HIV-1 RNA in plasma
22. An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma
23. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection
24. Quantitation of human immunodeficiency virus type 1 group O load in plasma by measuring reverse transcriptase activity
25. Genetic diversity and HIV detection by polymerase chain reaction
26. Comparative evaluation of two branched-DNA human immunodeficiency virus type 1 RNA quantification assays with lower detection limits of 50 and 500 copies per milliliter
27. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
28. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes
29. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: Application to acute retroviral infection
30. Impact of HIV type 1 subtype variation on viral RNA quantitation
31. Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient
32. Recombination in HIV-1: Update and implications
33. HIV-1 group O virus identified for the first time in the United States
34. Intersubtype recombinant HIV-1 sequences
35. HIV-1 nomenclature proposal
36. HIV viral load markers in clinical practice
37. HIV type 1 diversity in northern Paris, France
38. First case of HIV-1 group O infection in Spain
39. Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma
40. Quantification of HIV-1 group M (subtypes A-G) and group O by the LCx HIV RNA quantitative assay
41. Various types of HIV mixed infections in Cameroon
42. HIV-1 subtypes among blood donors from Rio de Janeiro
43. Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1
44. Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories